Analysed ELANCO ANIMAL HEALTH INC (ELAN:NYSE) News Sources
Elanco Confirms Date and Conference Call for Second Quarter 2026 Financial Results Announcement
08-07-2026
yahoo.com
Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
15-07-2026
yahoo.com
National Advertising Division Finds Certain PetIQ Claims Supported; Recommends Other Comparative Claims Be Modified or Discontinued
16-07-2026
yahoo.com
Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets)
22-07-2026
yahoo.com
Are You Looking for a Top Momentum Pick? Why Elanco Animal Health Incorporated (ELAN) is a Great Choice
22-07-2026
yahoo.com
Did New Tick-Data Edge for Credelio Quattro Just Shift Elanco Animal Health's (ELAN) Investment Narrative?
26-07-2026
yahoo.com
Elanco Seems Best-Positioned Into Q2 Print Among Animal Health Stocks, UBS Says
27-07-2026
yahoo.com
Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: Should You Buy?
29-07-2026
yahoo.com
What is the current price of ELANCO ANIMAL HEALTH INC (ELAN:NYSE)?
The current price of ELANCO ANIMAL HEALTH INC (ELAN:NYSE) is $26.37.
ELANCO ANIMAL HEALTH INC (ELAN:NYSE) absolute price change since previous trading day?
The absolute price change of ELANCO ANIMAL HEALTH INC (ELAN:NYSE) since the previous trading day is $-0.09.
ELANCO ANIMAL HEALTH INC (ELAN:NYSE) percentage price change since previous trading day?
The percentage price change of ELANCO ANIMAL HEALTH INC (ELAN:NYSE) since the previous trading day is -0.3401%.
What is the most recent average sentiment score for ELANCO ANIMAL HEALTH INC (ELAN:NYSE)?
The most recent average sentiment score for ELANCO ANIMAL HEALTH INC (ELAN:NYSE) is 69 out of 100.
What is the most recent average sentiment for ELANCO ANIMAL HEALTH INC (ELAN:NYSE)?
The most recent sentiment for ELANCO ANIMAL HEALTH INC (ELAN:NYSE) is .
SEC-8K** Filing Available For ELANCO ANIMAL HEALTH INC (ELAN:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.